Rochester Clinical Research is enrolling adults ages 50 to 64 for a vaccine research study focused on helping prevent C. diff infection.
If you are generally healthy and interested in participating in medical research, you may qualify.
C. diff Prevention
Age Range:
50 to 60
Gender:
Male and Female
Location:
Rochester, New York
About the Study
This study is testing an investigational vaccine designed to help protect against Clostridioides difficile (C. diff), a bacteria that can cause severe diarrhea and intestinal illness.
Qualifications
You may qualify if you:
- Are 50 to 64 years old
- Are generally healthy
- Are not currently diagnosed with C. diff infection
Additional eligibility criteria will be reviewed by the study team.
FEATURED STUDIES
Adults 18 to 80 years of age may qualify for a study evaluating an investigational treatment for irritable bowel syndrome […]
Are you 50 or older and in good general health? If you’ve had a pneumonia shot in the past (like Prevnar® or Pneumovax®), you […]
High blood pressure (hypertension) occurs when the force of blood against artery walls is consistently too high. Over time, this […]
Researchers are studying a new investigational medication, CRB-913, which works on pathways involved in appetite and metabolism. This study aims to […]
Influenza (flu) is a contagious respiratory illness that can lead to serious complications, especially in older adults and individuals with […]
We are currently enrolling a weight loss study evaluating the safety, tolerability and effectiveness of a GLP-1 and GIP medication. If […]